Quick Answer
NEUROONE MEDICAL TECHNOLOGIES Corp reported Common Stock Shares Outstanding of 50.01 million shares for the year ending 2025.
- NEUROONE MEDICAL TECHNOLOGIES Corp showed an increase of +62.3% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from NEUROONE MEDICAL TECHNOLOGIES Corp's annual report (Form 10-K), filed with the SEC on December 17, 2025.
- XBRL data for this metric is available from 2010 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 15 years of available data (2010 to 2025), NEUROONE MEDICAL TECHNOLOGIES Corp's Common Stock Shares Outstanding has grown by 1,011.3%.
- Historical annual values: Fiscal year 2025: 50.01 million shares | Fiscal year 2024: 30.82 million shares | Fiscal year 2023: 23.93 million shares | Fiscal year 2022: 16.22 million shares | Fiscal year 2021: 12.01 million shares | Fiscal year 2020: 7.39 million shares | Fiscal year 2019: 13.49 million shares | Fiscal year 2018: 9.66 million shares | Fiscal year 2017: 7.86 million shares | Fiscal year 2016: 5.22 million shares | Fiscal year 2015: 5.07 million shares | Fiscal year 2014: 5.07 million shares | Fiscal year 2013: 5.07 million shares | Fiscal year 2011: 5.07 million shares | Fiscal year 2010: 4.50 million shares.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: